The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
120 jobs Number of planned job creations
Announcement Date
1 September 2006
Employment effect (start)
Foreseen end date
Description
The American biotechnology company, Genzyme (whose products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant and immune disease, cancer, and diagnostic testing) currently employs more than 8,500 employees worldwide. On 1 September 2006, the company announced that 120 new jobs will be created soon at the Geel plant, which currently employs around 180 people.
Sources
1 September 2006: L'Echo
Citation
Eurofound (2006), Genzyme, Business expansion in Belgium, factsheet number 64004, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/64004.